PTPRO-associated hepatic stellate cell activation plays a critical role in liver fibrosis

Cellular Physiology and Biochemistry

Volumn 35, Issue 3, 2015, Pages 885-898

  Zhang, Xudong ^a   Tan, Zhongming ^a   Wang, Youjing ^a   Tang, Junwei ^a   Jiang, Runjiu ^a   Hou, Jiajie ^a   Zhuo, Han ^a   Wang, Xiaochen ^a   Ji, Jie ^a   Qin, Xihu ^a   Sun, Beicheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Bile duct ligation; CCl 4; Liver fibrosis; Platelet derived growth factor; PTPRO

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; BILIRUBIN; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; GELATINASE A; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE O; RECEPTOR; SHORT HAIRPIN RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PTPRO PROTEIN, MOUSE; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXPERIMENTAL LIVER FIBROSIS; FIBROGENESIS; GENE TARGETING; HUMAN; HUMAN TISSUE; KNOCKOUT MOUSE; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STELLATE CELL; SURVIVAL; TISSUE REGENERATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; CARBON TETRACHLORIDE; CELL PROLIFERATION; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84921908560     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369746     Document Type: Article

References (52)

1. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005;115:209-218.
2. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T: Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-209.
3. Friedman SL: Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.
4. Lee UE, Friedman SL: Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206.
5. Friedman SL: Evolving challenges in hepatic fibrosis. Nature Rev Gastroenterol Hepatol 2010;7:425-436.
6. Leask A, Abraham DJ: Tgf-beta signaling and the fibrotic response. FASEB J 2004;18:816-827.
7. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S: Liver fibrosis induced by hepatic overexpression of pdgf-b in transgenic mice. J Hepatol 2006;45:419-428.
8. Leclercq IA, Farrell GC, Schriemer R, Robertson GR: Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002;37:206-213.
9. Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, Cong M, Iwaisako K, Liu X, Zhang M, Osterreicher CH, Stickel F, Ley K, Brenner DA, Kisseleva T: Interleukin-17 signaling in inflammatory, kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012;143:765-776 e761-763.
10. Tan Z, Qian X, Jiang R, Liu Q, Wang Y, Chen C, Wang X, Ryffel B, Sun B: Il-17a plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation. J Immunol 2013;191:1835-1844.
11. McHedlidze T, Waldner M, Zopf S, Walker J, Rankin AL, Schuchmann M, Voehringer D, McKenzie AN, Neurath MF, Pflanz S, Wirtz S: Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013;39:357-371.
12. Tonks NK: Protein tyrosine phosphatases: From genes, to function, to disease. Nat Rev Mol Cell Biol 2006;7:833-846.
13. Matozaki T, Murata Y, Mori M, Kotani T, Okazawa H, Ohnishi H: Expression, localization, and biological function of the r3 subtype of receptor-type protein tyrosine phosphatases in mammals. Cell Signal 2010;22:1811-1817.
14. Chen B, Bixby JL: A novel substrate of receptor tyrosine phosphatase ptpro is required for nerve growth factor-induced process outgrowth. J Neurosci 2005;25:880-888.
15. Liao WH, Cheng CH, Hung KS, Chiu WT, Chen GD, Hwang PP, Hwang SP, Kuan YS, Huang CJ: Protein tyrosine phosphatase receptor type o (ptpro) regulates cerebellar formation during zebrafish development through modulating fgf signaling. Cell Mol Life Sci 2013;70:2367-2381.
16. Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, Tonks NK, Muthuswamy SK: Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies ptpro as a novel regulator of morphogenesis and erbb2-mediated transformation. Mol Cell Biol 2012;32:3913-3924.
17. You YJ, Chen YP, Zheng XX, Meltzer SJ, Zhang H: Aberrant methylation of the ptpro gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients. Cancer Lett 2012;315:138-144.
18. Motiwala T, Kutay H, Ghoshal K, Bai S, Seimiya H, Tsuruo T, Suster S, Morrison C, Jacob ST: Protein tyrosine phosphatase receptor-type o (ptpro) exhibits characteristics of a candidate tumor suppressor in human lung cancer. Proc Natl Acad Sci USA 2004;101:13844-13849.
19. Motiwala T, Ghoshal K, Das A, Majumder S, Weichenhan D, Wu YZ, Holman K, James SJ, Jacob ST, Plass C: Suppression of the protein tyrosine phosphatase receptor type o gene (ptpro) by methylation in hepatocellular carcinomas. Oncogene 2003;22:6319-6331.
20. Ramaswamy B, Majumder S, Roy S, Ghoshal K, Kutay H, Datta J, Younes M, Shapiro CL, Motiwala T, Jacob ST: Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase ptpro in human breast cancer: Mechanism and role in tamoxifen sensitivity. Mol Endocrinol 2009;23:176-187.
21. Hou J, Xu J, Jiang R, Wang Y, Chen C, Deng L, Huang X, Wang X, Sun B: Estrogen-sensitive ptpro expression represses hepatocellular carcinoma progression by control of stat3. Hepatology 2013;57:678-688.
22. Hou J, Xia Y, Jiang R, Chen D, Xu J, Deng L, Huang X, Wang X, Sun B: Ptpro plays a dual role in hepatic ischemia reperfusion injury through feedback activation of nf-kappab. J Hepatol 2014;60:306-312.
23. Fan X, Zhang Q, Li S, Lv Y, Su H, Jiang H, Hao Z: Attenuation of ccl4-induced hepatic fibrosis in mice by vaccinating against tgf-beta1. PLoS One 2013;8:e82190.
24. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, Llovet JM, Brenner DA, Schwabe RF: Ccr1 and ccr5 promote hepatic fibrosis in mice. J Clin Invest 2009;119:1858-1870.
25. Lechuga CG, Hernandez-Nazara ZH, Hernandez E, Bustamante M, Desierto G, Cotty A, Dharker N, Choe M, Rojkind M: Pi3k is involved in pdgf-beta receptor upregulation post-pdgf-bb treatment in mouse hsc. Am J Physiol Gastrointest Liver Physiol 2006;291:G1051-1061.
26. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.
27. Sonnweber T, Nachbaur D, Schroll A, Nairz M, Seifert M, Demetz E, Haschka D, Mitterstiller AM, Kleinsasser A, Burtscher M, Trubsbach S, Murphy AT, Wroblewski V, Witcher DR, Mleczko-Sanecka K, Vecchi C, Muckenthaler MU, Pietrangelo A, Theurl I, Weiss G: Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor bb. Gut 2014;63:1951-1959.
28. Bowen WC, Michalopoulos AW, Orr A, Ding MQ, Stolz DB, Michalopoulos GK: Development of a chemically defined medium and discovery of new mitogenic growth factors for mouse hepatocytes: Mitogenic effects of fgf1/2 and pdgf. PLoS One 2014;9:e95487.
29. Fang L, Zhan S, Huang C, Cheng X, Lv X, Si H, Li J: Trpm7 channel regulates pdgf-bb-induced proliferation of hepatic stellate cells via pi3k and erk pathways. Toxicol Appl Pharmacol 2013;272:713-725.
30. Friedman SL: Liver fibrosis-from bench to bedside. J Hepatol 2003;38:S38-53.
31. Lisbonne M, L'Helgoualc'h A, Nauwelaers G, Turlin B, Lucas C, Herbelin A, Piquet-Pellorce C, Samson M: Invariant natural killer t-cell-deficient mice display increased ccl(4)-induced hepatitis associated with cxcl1 over-expression and neutrophil infiltration. Eur J Immunol 2011;41:1720-1732.
32. Xu X, Hong Y, Kong C, Xu L, Tan J, Liang Q, Huang B, Lu J: Protein tyrosine phosphatase receptor-type o (ptpro) is co-regulated by e2f1 and mir-17-92. FEBS Lett 2008;582:2850-2856.
33. Pierga JY, Petit T, Delozier T, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roche H, Bachelot T, Charafe-Jauffret E, Pavlyuk M, Kraemer S, Bidard FC, Viens P: Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory her2-positive breast cancer (beverly-2): An open-label, single-arm phase 2 study. Lancet Oncol 2012;13:375-384.
34. Gobert RP, van den Eijnden M, Szyndralewiez C, Jorand-Lebrun C, Swinnen D, Chen L, Gillieron C, Pixley F, Juillard P, Gerber P, Johnson-Leger C, Halazy S, Camps M, Bombrun A, Shipp M, Vitte PA, Ardissone V, Ferrandi C, Perrin D, Rommel C, Hooft van Huijsduijnen R: Glepp1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis. J Biol Chem 2009;284:11385-11395.
35. Aschner Y, Khalifah AP, Briones N, Yamashita C, Dolgonos L, Young SK, Campbell MN, Riches DW, Redente EF, Janssen WJ, Henson PM, Sap J, Vacaresse N, Kapus A, McCulloch CA, Zemans RL, Downey GP: Protein tyrosine phosphatase alpha mediates profibrotic signaling in lung fibroblasts through tgf-beta responsiveness. Am J Pathol 2014;184:1489-1502.
36. Nishikawa Y, Ohi N, Yagisawa A, Doi Y, Yamamoto Y, Yoshida M, Tokairin T, Yoshioka T, Omori Y, Enomoto K: Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats. Am J Pathol 2009;174:881-890.
37. Bian EB, Huang C, Ma TT, Tao H, Zhang H, Cheng C, Lv XW, Li J: Dnmt1-mediated pten hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol 2012;264:13-22.
38. Hirschfield GM, Gershwin ME: The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 2013;8:303-330.
39. Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA: Systemic infusion of angiotensin ii exacerbates liver fibrosis in bile duct-ligated rats. Hepatology 2005;41:1046-1055.
40. Liu C, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG: Smads 2 and 3 are differentially activated by transforming growth factor-beta (tgf-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of smads in activated cells is tgf-beta-independent. J Biol Chem 2003;278:11721-11728.
41. Melton AC, Yee HF: Hepatic stellate cell protrusions couple platelet-derived growth factor-bb to chemotaxis. Hepatology 2007;45:1446-1453.
42. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, Efsen E, Laffi G, Gentilini P: Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 1999;30:951-958.
43. Kahraman A, Barreyro FJ, Bronk SF, Werneburg NW, Mott JL, Akazawa Y, Masuoka HC, Howe CL, Gores GJ: Trail mediates liver injury by the innate immune system in the bile duct-ligated mouse. Hepatology 2008;47:1317-1330.
44. Mair M, Zollner G, Schneller D, Musteanu M, Fickert P, Gumhold J, Schuster C, Fuchsbichler A, Bilban M, Tauber S, Esterbauer H, Kenner L, Poli V, Blaas L, Kornfeld JW, Casanova E, Mikulits W, Trauner M, Eferl R: Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis. Gastroenterology 2010;138:2499-2508.
45. Horiguchi N, Lafdil F, Miller AM, Park O, Wang H, Rajesh M, Mukhopadhyay P, Fu XY, Pacher P, Gao B: Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice. Hepatology 2010;51:1724-1734.
46. Deng YR, Ma HD, Tsuneyama K, Yang W, Wang YH, Lu FT, Liu CH, Liu P, He XS, Diehl AM, Gershwin ME, Lian ZX: Stat3-mediated attenuation of ccl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. J Autoimmun 2013;46:25-34.
47. Troeger JS, Schwabe RF: Hypoxia and hypoxia-inducible factor 1alpha: Potential links between angiogenesis and fibrogenesis in hepatic stellate cells. Liver Int 2011;31:143-145.
48. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, Brenner DA: Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 2003;37:1043-1055.
49. Pinzani M: Pdgf and signal transduction in hepatic stellate cells. Front Biosci 2002;7:d1720-1726.
50. Nakamura I, Zakharia K, Banini BA, Mikhail DS, Kim TH, Yang JD, Moser CD, Shaleh HM, Thornburgh SR, Walters I, Roberts LR: Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of fgf, vegf and pdgf signaling. PLoS One 2014;9:e92273.
51. Liu Y, Wang Z, Kwong SQ, Lui EL, Friedman SL, Li FR, Lam RW, Zhang GC, Zhang H, Ye T: Inhibition of pdgf, tgf-beta, and abl signaling and reduction of liver fibrosis by the small molecule bcr-abl tyrosine kinase antagonist nilotinib. J Hepatol 2011;55:612-625.
52. Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E: Octreotide modulates the effects on fibrosis of tnf-alpha, tgf-beta and pdgf in activated rat hepatic stellate cells. Regul Pept 2014;188:5-12.